Xia Wang

6.8k total citations · 2 hit papers
200 papers, 5.0k citations indexed

About

Xia Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xia Wang has authored 200 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 65 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Xia Wang's work include RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (21 papers) and Viral-associated cancers and disorders (12 papers). Xia Wang is often cited by papers focused on RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (21 papers) and Viral-associated cancers and disorders (12 papers). Xia Wang collaborates with scholars based in China, United States and Germany. Xia Wang's co-authors include Erik K. Flemington, Zhen Lin, Qinyan Yin, Claire Fewell, Irene Oi‐Lin Ng, Jane McBride, Lü Tian, Jennifer Cameron, Yong Lin and Wenshu Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Xia Wang

191 papers receiving 5.0k citations

Hit Papers

Exosomes and cancer - Diagnostic and prognostic biomarker... 2022 2026 2023 2024 2022 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Wang China 38 3.3k 1.2k 996 544 404 200 5.0k
Ammad Ahmad Farooqı Pakistan 39 3.3k 1.0× 1.5k 1.2× 755 0.8× 485 0.9× 364 0.9× 227 5.4k
Yi Wang China 41 3.1k 1.0× 1.2k 1.0× 1.2k 1.2× 432 0.8× 284 0.7× 266 6.3k
Dragana Nikitovic Greece 42 2.7k 0.8× 768 0.6× 786 0.8× 484 0.9× 282 0.7× 122 6.0k
Cornelia Braicu Romania 41 3.0k 0.9× 1.7k 1.4× 718 0.7× 382 0.7× 536 1.3× 163 5.4k
Bin Bao United States 41 3.5k 1.1× 2.0k 1.6× 1.4k 1.4× 487 0.9× 308 0.8× 84 6.5k
Lei Fang China 39 2.9k 0.9× 1.1k 0.9× 628 0.6× 859 1.6× 382 0.9× 251 5.4k
Chien‐Chih Chiu Taiwan 41 2.8k 0.8× 806 0.7× 563 0.6× 455 0.8× 321 0.8× 199 5.2k
George N. Tzanakakis Greece 49 3.3k 1.0× 1.2k 0.9× 1.3k 1.3× 496 0.9× 455 1.1× 167 7.3k
Mingxing Li China 40 2.6k 0.8× 1.1k 0.9× 917 0.9× 700 1.3× 295 0.7× 192 5.4k
Wenjie Wang China 35 2.7k 0.8× 1.0k 0.8× 532 0.5× 325 0.6× 270 0.7× 152 4.5k

Countries citing papers authored by Xia Wang

Since Specialization
Citations

This map shows the geographic impact of Xia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Wang more than expected).

Fields of papers citing papers by Xia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Wang. The network helps show where Xia Wang may publish in the future.

Co-authorship network of co-authors of Xia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Wang. A scholar is included among the top collaborators of Xia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Wang. Xia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Rui, Zhi Ji, Xia Wang, et al.. (2025). Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial. Nature Communications. 16(1). 1481–1481. 5 indexed citations
2.
Wang, Xia, Shipeng Ning, Wenhui Tao, et al.. (2024). Cytomembrane-targeted photodynamic priming triggers extracellular vesicle storm for deep penetration and complete destruction of bladder cancer. Nano Today. 56. 102311–102311. 10 indexed citations
3.
Sun, Jingfeng, Xu Wang, Shuangyu Li, et al.. (2024). H2S scavenger as a broad-spectrum strategy to deplete bacteria-derived H2S for antibacterial sensitization. Nature Communications. 15(1). 9422–9422. 9 indexed citations
4.
Wang, Xia, Hongyang Huang, Karen Man‐Fong Sze, et al.. (2023). S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos. Gut. 72(7). 1370–1384. 27 indexed citations
5.
Li, Shengyu, Lifeng Feng, Guangru Li, et al.. (2023). GSDME-dependent pyroptosis signaling pathway in diabetic nephropathy. Cell Death Discovery. 9(1). 156–156. 17 indexed citations
6.
Feng, Panpan, Dawei Chen, Xia Wang, et al.. (2022). Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia. 36(9). 2180–2188. 57 indexed citations
7.
Wang, Xia, et al.. (2021). Rid Enhances the 6-Hydroxypseudooxynicotine Dehydrogenase Reaction in Nicotine Degradation by Agrobacterium tumefaciens S33. Applied and Environmental Microbiology. 87(7). 4 indexed citations
8.
Guo, Wei, Cuiyu Zhang, Xia Wang, et al.. (2021). Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing. JCI Insight. 7(1). 58 indexed citations
9.
Ungerleider, Nathan, et al.. (2021). EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. PLoS Pathogens. 17(5). e1009217–e1009217. 26 indexed citations
10.
Guo, Wei, Cuiyu Zhang, Panpan Feng, et al.. (2021). M6A methylation of DEGS2, a key ceramide-synthesizing enzyme, is involved in colorectal cancer progression through ceramide synthesis. Oncogene. 40(40). 5913–5924. 24 indexed citations
11.
Wang, Xia, et al.. (2021). An NAD-Specific 6-Hydroxy-3-Succinoyl-Semialdehyde-Pyridine Dehydrogenase from Nicotine-Degrading Agrobacterium tumefaciens Strain S33. Microbiology Spectrum. 9(1). e0092421–e0092421. 3 indexed citations
12.
Pu, Yingying, et al.. (2020). Severe hyponatremia in preeclampsia: a case report and review of the literature. Archives of Gynecology and Obstetrics. 303(4). 925–931. 4 indexed citations
13.
Zhang, Tao, Shiliang Li, Linjiang Tong, et al.. (2019). Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFRL858R/T790M/C797S. ACS Medicinal Chemistry Letters. 10(6). 869–873. 52 indexed citations
15.
Zhou, Li, Xia Wang, Analyn Lizaso, et al.. (2019). <p>Efficacy of afatinib in a <em>HER2</em> amplification-positive endometrioid adenocarcinoma patient– a case report</p>. OncoTargets and Therapy. Volume 12. 5305–5309. 3 indexed citations
16.
Strong, Michael J., Thomas Laskow, Eugene Blanchard, et al.. (2015). Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a , in EBV-Positive Gastric Carcinomas. Journal of Virology. 89(19). 10110–10114. 28 indexed citations
17.
Wang, Xia, Lei Zhu, Baoquan Liu, et al.. (2007). Arabidopsis MICROTUBULE-ASSOCIATED PROTEIN18 Functions in Directional Cell Growth by Destabilizing Cortical Microtubules. The Plant Cell. 19(3). 877–889. 130 indexed citations
18.
Lin, Yong, et al.. (2006). [Study on bisphenol A induced primary cultured mesencephalic neuronal cell injury by oxidative stress].. PubMed. 35(4). 419–22. 11 indexed citations
19.
Wang, Xia. (2005). Growth factors of unialgal strain and axenic strain of Microcystis aeruginosa in Songhua Lake.. Shengtaixue zazhi. 1 indexed citations
20.
Wang, Xia, et al.. (2004). Fusion expression and purification of HA20-lys10 in E. coli and its gel retardation experiments. 31(1). 32–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026